☆ 4.7 Article

Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years

JOURNAL OF CLINICAL ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Breast Cancer, Version 4.2023

William J. Gradishar et al.

Summary: The NCCN Clinical Practice Guidelines for Breast Cancer cover all aspects of breast cancer management. The treatment approach considers tumor biology, biomarkers, and other clinical factors. This report focuses on recent updates in systemic therapy recommendations for patients with stage IV (M1) disease, as the treatment landscape for metastatic breast cancer is constantly evolving.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2023)

Add to Collection

Article Medicine, General & Internal

Projected estimates of cancer in Canada in 2022

Darren R. Brenner et al.

Summary: This study provides an overview of the expected burden of cancer in Canada in 2022. It predicts that there will be approximately 233,900 new cancer cases and 85,100 cancer deaths. Lung cancer, breast cancer, and prostate cancer are expected to be the most commonly diagnosed cancers. The study also indicates that cancer incidence and mortality rates are generally higher in the eastern provinces of Canada compared to the western provinces. The findings emphasize the importance of increasing tobacco control, improving early detection and treatment, and strengthening breast and colorectal cancer screening and treatment.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)

Add to Collection

Review Oncology

Global guidelines for breast cancer screening: A systematic review*

Wenhui Ren et al.

Summary: This study systematically reviewed international breast cancer screening guidelines and found that the majority of guidelines issued by developed countries had similar but not identical recommendations on screening age, methods, and intervals. Most guidelines recommended annual or biennial mammographic screening for average-risk populations between 40 and 74 years, while high-risk populations were advised to start screening at a younger age and consider annual mammography or annual MRI. The quality of the guidelines varied, and efforts are needed to improve methodological quality. Low- and middle-income countries should adapt and implement evidence-based guidelines with higher quality scores.

BREAST (2022)

Add to Collection

Article Oncology

Overdiagnosis of invasive breast cancer in population-based breast cancer screening: A short- and long-term perspective

Lilu Ding et al.

Summary: This study aimed to estimate the overdiagnosis rate of invasive breast cancer in an organised screening program, with results showing a higher overdiagnosis issue in older women and the importance of sufficient follow-up time for obtaining accurate estimates.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59

Anna N. Wilkinson et al.

Summary: This study assessed the relationship between mammography screening practices for women 40-49 and breast cancer stage at diagnosis in women 40-49 and 50-59 years. The results showed that women aged 40-49 were diagnosed with more advanced stages of breast cancer, indicating a need for reassessment of the optimum age for breast cancer screening in Canada.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Oncology

Overdetection of Breast Cancer

Martin J. Yaffe et al.

Summary: Overdetection, or overdiagnosis, refers to the detection of diseases, such as through screening, that would otherwise remain undetected throughout an individual's life. The main harm of overdetection is subsequent overdiagnosis and overtreatment. The actual amount of overdetection is likely to be lower than estimated, and this issue is more significant in older women due to competing causes of death. Possible approaches to avoiding overtreatment for in situ breast cancer are discussed.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Oncology

Factors associated with late risks of breast cancer-specific mortality in the SEER registry

Jose P. Leone et al.

Summary: This study investigated the long-term risks of breast cancer-specific mortality (BCSM) beyond 5 years after diagnosis, and found that factors such as hormone receptor status, T-N staging, age, year of diagnosis, race, and grade were associated with late BCSM. Strategies to prevent both early and late recurrences of breast cancer are deemed necessary based on the findings.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Add to Collection

Article Oncology

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

Rosie Bradley et al.

LANCET ONCOLOGY (2021)

Add to Collection

Article Oncology

Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium

Karla Kerlikowske et al.

Summary: This study compared different classifications of advanced cancer in predicting breast cancer death, with the conclusion that defining advanced cancer as AJCC prognostic pathologic stage IIA or higher most accurately predicts breast cancer death.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Article Genetics & Heredity

A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect

Lesa M. Dawson et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Estimating the magnitude of cancer overdiagnosis in Australia

Paul P. Glasziou et al.

MEDICAL JOURNAL OF AUSTRALIA (2020)

Add to Collection

Article Oncology

Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women

Stephen W. Duffy et al.

CANCER (2020)

Add to Collection

Article Oncology

Modeling the natural history of ductal carcinoma in situ based on population data

Sarocha Chootipongchaivat et al.

BREAST CANCER RESEARCH (2020)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Screening Mammography in Women 40-49 Years Old: Current Evidence

Kimberly M. Ray et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for US Women

R. Edward Hendrick

RADIOLOGY (2018)

Add to Collection

Review Medicine, General & Internal

Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer

Scott Klarenbach et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)

Add to Collection

Review Medicine, General & Internal

Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 US Preventive Services Task Force Recommendation

Heidi D. Nelson et al.

ANNALS OF INTERNAL MEDICINE (2016)

Add to Collection

Article Oncology

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study

Stephen W. Duffy et al.

LANCET ONCOLOGY (2016)

Add to Collection

Article Public, Environmental & Occupational Health

Revised estimates of overdiagnosis from the Canadian National Breast Screening Study

Cornelia J. Baines et al.

PREVENTIVE MEDICINE (2016)

Add to Collection

Review Medicine, General & Internal

Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society

Kevin C. Oeffinger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Add to Collection

Article Medicine, General & Internal

Breast-Cancer Screening - Viewpoint of the IARC Working Group

Beatrice Lauby-Secretan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Oncology

Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status

Diana L. Miglioretti et al.

JAMA ONCOLOGY (2015)

Add to Collection

Article Oncology

Cancer incidence, survival and mortality: Explaining the concepts

Libby Ellis et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

Add to Collection

Article Oncology

Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer

Andrew Coldman et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Add to Collection

Article Oncology

How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden

Sandra Eloranta et al.

CANCER CAUSES & CONTROL (2013)

Add to Collection

Article Biology

On Estimation in Relative Survival

Maja Pohar Perme et al.

BIOMETRICS (2012)

Add to Collection

Review Public, Environmental & Occupational Health

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

Donella Puliti et al.

JOURNAL OF MEDICAL SCREENING (2012)

Add to Collection

Review Medicine, General & Internal

Recommendations on screening for breast cancer in average-risk women aged 40-74 years

J. Dickinson et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)

Add to Collection

Article Oncology

Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years Evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort

Barbro Numan Hellquist et al.

CANCER (2011)

Add to Collection

Article Obstetrics & Gynecology

The Timing of the Age at Which Natural Menopause Occurs

Ellen B. Gold

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2011)

Add to Collection

Article Oncology

Measuring the effect of including multiple cancers in survival analyses using data from the Canadian Cancer Registry

Larry F. Ellison

CANCER EPIDEMIOLOGY (2010)

Add to Collection

Article Oncology

Bias Associated With Self-Report of Prior Screening Mammography

Kathleen A. Cronin et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)

Add to Collection

Review Medicine, General & Internal

Interpreting trends in cancer patient survival

P. W. Dickman et al.

JOURNAL OF INTERNAL MEDICINE (2006)

Add to Collection

Article Medicine, General & Internal

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

MJ Piccart-Gebhart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Oncology

Biennial versus annual mammography and the risk of late-stage breast cancer

E White et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)

Add to Collection

Article Public, Environmental & Occupational Health

Number needed to screen: lives saved over 20 years of follow-up in mammographic screening

L Tabar et al.

JOURNAL OF MEDICAL SCREENING (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.